ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 792,07
-1,29%
Dow Jones
38 654,74
-0,55%
DAX
18 346,26
-0,77%
Brent Oil
81,42
-0,43%
Bitcoin
66 932,09
-3,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AngioDynamics Inc (ANGO)

  7. AngioDynamics Inc (ANGO) Actualités

ANGO

AngioDynamics (ANGO)

AngioDynamics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANGO
DateHeureSourceTitreSymboleSociété
21/05/202423h30Business WireAngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ SystemNASDAQ:ANGOAngioDynamics Inc
06/05/202422h45Business WireAngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsNASDAQ:ANGOAngioDynamics Inc
04/04/202413h31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:ANGOAngioDynamics Inc
04/04/202413h00Business WireAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureNASDAQ:ANGOAngioDynamics Inc
04/04/202412h45Business WireAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PENASDAQ:ANGOAngioDynamics Inc
01/04/202423h26Business WireAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.NASDAQ:ANGOAngioDynamics Inc
19/03/202421h01Business WireAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024NASDAQ:ANGOAngioDynamics Inc
06/03/202422h01Business WireAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services ConferenceNASDAQ:ANGOAngioDynamics Inc
05/03/202402h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
15/02/202422h05Business WireAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 MillionNASDAQ:ANGOAngioDynamics Inc
23/01/202422h14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGOAngioDynamics Inc
23/01/202414h00Business WireAngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial DiseaseNASDAQ:ANGOAngioDynamics Inc
22/01/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
08/01/202422h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGOAngioDynamics Inc
05/01/202413h00Business WireAngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 GuidanceNASDAQ:ANGOAngioDynamics Inc
21/12/202322h01Business WireAngioDynamics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:ANGOAngioDynamics Inc
07/12/202322h01Business WireAngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024NASDAQ:ANGOAngioDynamics Inc
07/12/202314h00Business WireAngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary EmbolismNASDAQ:ANGOAngioDynamics Inc
07/11/202314h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ANGOAngioDynamics Inc
04/10/202313h22IH Market NewsWednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine, A10 Networks, and moreNASDAQ:ANGOAngioDynamics Inc
04/10/202313h00Business WireAngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 GuidanceNASDAQ:ANGOAngioDynamics Inc
22/09/202303h28Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
12/09/202322h01Business WireAngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023NASDAQ:ANGOAngioDynamics Inc
02/09/202300h51PR Newswire (US)Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600NASDAQ:ANGOAngioDynamics Inc
15/08/202322h01Business WireAngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart VegetationNASDAQ:ANGOAngioDynamics Inc
03/08/202323h16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGOAngioDynamics Inc
03/08/202314h00Business WireAngioDynamics Completes Enrollment for PRESERVE Clinical StudyNASDAQ:ANGOAngioDynamics Inc
31/07/202322h01Business WireAngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth ConferenceNASDAQ:ANGOAngioDynamics Inc
24/07/202322h01Business WireAngioDynamics Announces Addition of Lorinda Burgess to Board of DirectorsNASDAQ:ANGOAngioDynamics Inc
22/07/202302h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
 Showing the most relevant articles for your search:NASDAQ:ANGO

Dernières Valeurs Consultées

BOV
BRFSX13
BRFSX13 Ex:13
BIT
F23524
Vontobel Financial Produ...
AQSE
JPS.GB
JPMorgan Japan Small Cap...
BIT
TNXT
Tinexta
BIT
S28935
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés